Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies

Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies

Background: High mobility group box 1 (HMGB1), soluble receptor of advanced glycation end products (sRAGE) and programmed cell death markers PD-1 and PD-L1 are immunogenic serum biomarkers that may serve as novel diagnostic tools for cancer diagnosis. Methods: We investigated the four markers in ser...

Full description

Bibliographic Details
Main Authors: Lars Schröder, Alexander B. A. Rupp, Kathrin M. E. Gihr, Makbule Kobilay, Christian M. Domroese, Michael R. Mallmann, Stefan Holdenrieder
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
HMGB1
RAGE
PD1
PD-L1
ovarian cancer
diagnosis
Online Access:https://www.mdpi.com/2072-6694/15/20/5081

Internet

https://www.mdpi.com/2072-6694/15/20/5081

Similar Items